- Home
- BELFB vs AVDL Comparison
BELFB vs AVDL Comparison
Compare BELFB & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BELFB
- AVDL
- Stock Information
- Founded
- BELFB 1949
- AVDL 2015
- Country
- BELFB United States
- AVDL Ireland
- Employees
- BELFB N/A
- AVDL N/A
- Industry
- BELFB
- AVDL Biotechnology: Pharmaceutical Preparations
- Sector
- BELFB
- AVDL Health Care
- Exchange
- BELFB Nasdaq
- AVDL Nasdaq
- Market Cap
- BELFB 1.1B
- AVDL 963.6M
- IPO Year
- BELFB N/A
- AVDL 1996
- Fundamental
- Price
- BELFB $83.78
- AVDL $10.31
- Analyst Decision
- BELFB Strong Buy
- AVDL Strong Buy
- Analyst Count
- BELFB 3
- AVDL 6
- Target Price
- BELFB $98.33
- AVDL $24.00
- AVG Volume (30 Days)
- BELFB 66.5K
- AVDL 1.3M
- Earning Date
- BELFB 02-19-2025
- AVDL 11-12-2024
- Dividend Yield
- BELFB 0.33%
- AVDL N/A
- EPS Growth
- BELFB N/A
- AVDL N/A
- EPS
- BELFB 4.32
- AVDL N/A
- Revenue
- BELFB $524,943,000.00
- AVDL $138,160,000.00
- Revenue This Year
- BELFB N/A
- AVDL $523.86
- Revenue Next Year
- BELFB $0.77
- AVDL $70.46
- P/E Ratio
- BELFB $19.67
- AVDL N/A
- Revenue Growth
- BELFB N/A
- AVDL 1523.50
- 52 Week Low
- BELFB $45.75
- AVDL $9.41
- 52 Week High
- BELFB $92.61
- AVDL $19.09
- Technical
- Relative Strength Index (RSI)
- BELFB 52.74
- AVDL 41.51
- Support Level
- BELFB $83.00
- AVDL $10.35
- Resistance Level
- BELFB $92.61
- AVDL $11.15
- Average True Range (ATR)
- BELFB 3.50
- AVDL 0.59
- MACD
- BELFB -0.07
- AVDL 0.10
- Stochastic Oscillator
- BELFB 27.44
- AVDL 44.34
About BELFB Bel Fuse Inc. Class B
Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.
About AVDL Avadel Pharmaceuticals plc
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.